CollPlant Biotechnologies Ltd (CLGN) Return on equity 2018–2025
CollPlant Biotechnologies Ltd (CLGN) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-188.9%FY2025 · since FY2018: -115.3% → -188.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -188.9% | -65.6 pp |
| FY2024 | -123.3% | -98.6 pp |
| FY2023 | -24.8% | +27.7 pp |
| FY2022 | -52.4% | -53.0 pp |
| FY2021 | 0.5% | +129.5 pp |
| FY2020 | -129.0% | +144.1 pp |
| FY2019 | -273.1% | -157.8 pp |
| FY2018 | -115.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice